Saudi Journal of Medical and Pharmaceutical Sciences (SJMPS)
Volume-4 | Issue-10 | 1184-1189
Original Research Article
Evaluation of Thiazole Derivatives for M. tuberculosis and dTDP-rhamnose Inhibitors
Rajendra Dighe, Avinash B. Gangurde, Sheetal Dighe, Prashant Dighe, Rishikesh S. Bachhav, Sandip B. Ahire, Amol M. Shirode, Pravin B. Jadhav, Vinod A. Bairagi
Published : Oct. 30, 2018
Abstract
To determine antimycobacterium and dTDP rhamnose inhibitor activity of the synthesized azetidinone, thiazolidinone derivatives of thiazole, we studied different derivatives for the activity. One pot synthesis of 2-amino-4-methylthiazole-5-carboxylic acid ethyl ester has been carried out and synthesized different derivative compounds. Compounds were tested for antimicrobial activity against different strains of microorganism and antitubercular activity against M. tuberculosis H37Rv. Compounds 7c, 7d, 7i, 8d, 8e, 8g and 8h, were showed antimicrobial activity against Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Salmonella typhosa using Gentamycin as standard, while 7b, 7e, 7f, 7i, 8b, 8e, 8f and 8i showed very strong antimycobacterial activity using rifampicine as a standard. Thiazole derivatives especially with carbonyl group scaffold inhibit an enzyme RmlC, which is an essential component for the biosynthesis of dTDP-rhamnose and produce good antimycobacterium and antimicrobial activity.